PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

Similar documents
Package Leaflet: Information for the user. TARGAXAN 550 mg film-coated tablets rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package Leaflet: Information for the User

If you have any questions about how Letrozole Tablets works or why this medicine has been prescribed for you, ask your doctor.

Package leaflet: Information for the patient

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package leaflet: Information for the patient. Destolit 150 mg tablets Ursodeoxycholic acid

ALDOMET Film-coated Tablets 250 mg ALDOMET Film-coated Tablets 500 mg (Methyldopa)

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

Package leaflet: Information for the user

Zinnat can also be used: to treat Lyme disease (an infection spread by parasites called ticks).

Package leaflet: Information for the user

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

PATIENT INFORMATION LEAFLET. ZITHROMAX 250mg Capsules azithromycin

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the user Montelukast 10 mg film-coated tablets Montelukast

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Some general information on hepatitis A infection is given at the end of this leaflet.

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

Package leaflet: Information for the user. PARIET 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium

PATIENT INFORMATION LEAFLET AMLOC RANGE

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

If you need the information on this leaflet in an alternative format, such as large text, or Braille please ring from the UK:

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

Package Leaflet: Information for the patient. Movicol Ready to Take oral solution in sachet

PATIENT INFORMATION LEAFLET CARZIN XL

XYZAL 5 MG FILM-COATED TABLET

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Package leaflet: Information for the user. Cinfalair10 mg film-coated tablets montelukast

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Motens 2 mg and 4 mg Tablets lacidipine

PACKAGE LEAFLET: INFORMATION FOR THE USER Cinfalair 10 mg film-coated tablets Montelukast

Package leaflet: Information for the user. Exemestane 25 mg coated tablets exemestane

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Sibelium 5 mg Tablets flunarizine

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cinfalair 4 mg chewable tablets

Package leaflet: Information for the user. Melatonin Pharma Nord 3 mg, film-coated tablets melatonin

Package leaflet: Information for users. Imodium 2 mg orodispersible tablets Loperamide hydrochloride

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

Otezla (apremilast) film coated tablets

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

Package leaflet: Information for the patient

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Dulcolax 5 mg, film-coated tablets

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the user. Sebivo 600 mg film-coated tablets Telbivudine

PATIENT INFORMATION LEAFLET

1. What Betahistine dihydrochloride tablets is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET

Zinnat can also be used: to treat Lyme disease (an infection spread by parasites called ticks).

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package leaflet: Information for the patient. Moventig 12.5 mg film-coated tablets Moventig 25 mg film-coated tablets. naloxegol

NORVASC 5 mg and 10 mg tablets

Package leaflet: Information for the user. Fluvastatin

Package leaflet: Information for the user NON DROWSY SUDAFED. DECONGESTANT 60 mg FILM-COATED TABLETS Pseudoephedrine hydrochloride

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

What is in this leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)

Package leaflet: Information for the patient. Onglyza 2.5 mg film-coated tablets Onglyza 5 mg film-coated tablets Saxagliptin

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

SINGULAIR JUNIOR 5mg chewable tablets

Simplotan* tablets Tinidazole (tin-id-azole)

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

2. What you need to know before you take Bisoprolol Tablets

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 30 mg film-coated tablets risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package leaflet: Information for the user

Package leaflet: Information for the user Salofalk 500mg gastro-resistant tablets Mesalazine

Package leaflet: Information for the patient. Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets Hydrocortisone

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Xifaxanta 200 mg film-coated tablets are and what they are used for 2. What you need to know before you take Xifaxanta 200 mg film-coated tablets 3. How to take Xifaxanta 200 mg film-coated tablets 4. Possible side effects 5. How to store Xifaxanta 200 mg film-coated tablets 6. Contents of the pack and other information 1. WHAT XIFAXANTA 200 MG FILM-COATED TABLETS ARE AND WHAT THEY ARE USED FOR XIFAXANTA 200 mg film-coated tablets contain the active substance Rifaximin, an intestinal antibiotic used to treat: traveller s diarrhoea in adults when the diarrhoea is not accompanied by fever or blood in the stools, or 8 or more unformed (soft or liquid) stools in the last 24 hours. Xifaxanta 200 mg film-coated tablets are not recommended for use in children (aged less than 18 years). You must talk to a doctor if you do not feel better or if you feel worse after 3 days 1

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE XIFAXANTA 200 MG FILM-COATED TABLETS Do not take Xifaxanta 200 mg film-coated tablets if you are allergic (hypersensitive) to rifaximin, to similar types of antibiotics (such as rifampicin or rifabutin) or to any of the other ingredients of this medicine (listed in section 6) if you have a fever; if you have blood in your stools; if you passed 8 or more unformed stools in the last 24 hours. if you have constipation, abdominal pain and vomiting caused by blockage of the bowel Warning and Precautions Talk to your doctor or pharmacist before taking Xifaxanta 200mg film coated tablets and take special care; if, after 3 days of treatment, your symptoms continue or re-appear shortly afterwards do not take a second course of Xifaxanta 200 mg film-coated tablets, see a doctor if your symptoms get worse during treatment stop taking Xifaxanta 200 mg film-coated tablets and consult a doctor. Other medicines and Xifaxanta 200mg film coated tablets Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. Please tell your doctor if you are taking ciclosporin (a medicine to suppress the body s immune system), warfarin (medicine to prevent blood clotting) or oral contraceptives (medicines to prevent pregnancy). If you are using activated charcoal (for example to treat wind or diarrhoea) please take Xifaxanta 200 mg film-coated tablets at least 2 hours after taking charcoal. Xifaxanta 200 mg film-coated tablets with food and drink Xifaxanta 200 mg film-coated tablets can be taken with or without food. Orally with a glass of water. Taking this medicine may cause a reddish discolouration of your urine 2

Pregnancy, breast-feeding and fertility Xifaxanta 200 mg film-coated tablets are not recommended during pregnancy or in fertile women not using contraception. Inform your doctor if you are pregnant, think you may be pregnant or are thinking of becoming pregnant if you are breast-feeding or planning to start breast-feeding. Ask your doctor or pharmacist for advice before taking any medicine. Driving and using machines Xifaxanta 200 mg film-coated tablets are unlikely to affect your reactions when driving or using machines. If you feel dizzy or drowsy you should not drive or operate machinery 3. HOW TO TAKE XIFAXANTA 200 MG FILM-COATED TABLETS Always take Xifaxanta 200 mg film-coated tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Unless otherwise prescribed by the doctor, the usual dose is 1 tablet every 8 hours (600 mg/day). You should continue taking Xifaxanta 200 mg film-coated tablets for three days even if your symptoms have improved. Unless otherwise prescribed, the duration of the treatment should not exceed three days. If your symptoms persist for more than three days please see a doctor. Do not break or crush the tablets. If you take more Xifaxanta 200 mg film-coated tablets than you should If you take more than the recommended number of tablets, please contact a doctor. If you forget to take Xifaxanta 200 mg film-coated tablets take the missed dose as soon as you remember and take the next scheduled dose at its regular time. 3

If you stop taking Xifaxanta 200 mg film-coated tablets If you do not complete the three days of treatment recommended, your symptoms may worsen. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Xifaxanta 200 mg film-coated tablets can cause side effects, although not everybody gets them. If you have any of the following side effects stop taking Xifaxanta 200 mg film-coated tablets and seek urgent medical advice immediately. These may be symptoms of a severe allergic reaction: rash, hives or itchy skin, shortness of breath, wheezing heart racing swelling of the mouth, face, ankles or any other part of the body, extreme tiredness, dizziness or feeling faint Common (may affect up to 1 in 10 people): headache wind, abdominal bloating, abdominal pain, constipation, diarrhoea, urgency to empty your bowels, nausea, involuntary and painful or ineffective straining, vomiting fever. Uncommon (may affect up to 1 in 100 people): thrush, cold sore, inflammation or infection of the nose and throat abnormal test results in white blood cells loss of appetite, loss of body fluid (dehydration) abnormal dreams, depressed mood, sleeplessness, nervousness numbness, migraine, pins and needles, sinus headache, drowsiness double vision earache, sensation of the room going round (vertigo) increased blood pressure, hot flushes 4

cough, dry throat, blocked nose, sore throat, runny nose upper abdominal pain, indigestion, intestinal movement disorder, dry lips, hard stools, blood in the stools, mucus in stools, taste disorders blood test results: increased liver enzyme values sunburn back pain, muscle cramps, muscle weakness, muscle pain, neck pain abnormal urine test results: blood in urine, protein in urine, sugar in urine, frequent urination, excessive urination frequent periods chills, cold sweat, increased sweating, flu-like illness, pain. The following side effects have been reported, however their frequency cannot be estimated from the available data: bacterial infections abnormal blood tests results (blood not clotting normally and abnormal liver tests) ) allergic reactions to the drug skin roughness, skin redness, - skin with little purple-coloured spots. Treatment with any antibiotic may cause Clostridium difficile associated diarrhoea (CDAD). Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE XIFAXANTA 200 MG FILM-COATED TABLETS Keep out of the sight and reach of children. Xifaxanta 200 mg film-coated tablets do not require any special storage conditions. Do not use Xifaxanta 200 mg film-coated tablets after the expiry date which is stated on the carton and the blister. The expiry date refers to the last day of that month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 5

6. CONTENTS OF THE PACK AND OTHER INFORMATION What Xifaxanta 200 mg film-coated tablets contain The active substance is: Rifaximin. Each film-coated tablet contains: 200 mg of Rifaximin. The other ingredients are: Tablet core: sodium starch glycolate type A, glycerol distearate, colloidal anhydrous silica, talc, microcrystalline cellulose. Tablet coating: hypromellose, titanium dioxide E171, disodium edetate, propylene glycol, red iron oxide E172. What Xifaxanta 200 mg film-coated tablets look like and contents of the pack Xifaxanta 200 mg film-coated tablets are pink circular biconvex coated tablets, with AW embossed on one side. They are provided in a blister pack containing 9 tablets. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: Norgine Pharmaceuticals Ltd. Moorhall Rd, Harefield, Middx, UB9 6NS, U.K. Manufacturer: Alfasigma S.p.A. Via E. Fermi, 1 65020 Alanno (PE), ITALY If you need the information on this leaflet in an alternative format, such as large text, please ring Medical Information on 01895 826 606. This leaflet was last revised in July 2018 6